Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Gastrointestinal OncologyOpen Access

Survival outcomes and prognostic factors of advanced gastrointestinal stromal tumors: in the era of multiple tyrosine kinase inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJinjin LiZHZhen HuangHZHui Zhou

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e66c6fb6db6435875f7be2https://doi.org/10.21037/jgo-24-63
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study2024 · 4 citations
  2. 2Prognostic factors for metastatic gastrointestinal stromal tumors treated with cytoreductive surgery: a retrospective cohort study.2025
  3. 3Integrating surgery and targeted therapies in the management of recurrent/metastatic gastrointestinal stromal tumors2025
  4. 4Adjuvant treatment of gastrointestinal stromal tumors (GIST)—state of the art, controversies, and future directions2026
  5. 5Impact of neoadjuvant imatinib duration and tumor response on recurrence-free survival in locally advanced gastrointestinal stromal tumors: a retrospective multicenter cohort study2026 · 2 citations